<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01332734</url>
  </required_header>
  <id_info>
    <org_study_id>2010-03.03 nr BE-2-6</org_study_id>
    <nct_id>NCT01332734</nct_id>
  </id_info>
  <brief_title>Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis</brief_title>
  <official_title>Microcirculatory Changes During Open Label Magnesium Sulphate Infusion in Severe Sepsis and Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Centre Leeuwarden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lithuanian University of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical Centre Leeuwarden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During infections (sepsis) bloodflow in small vessels (microcirculation) becomes disturbed.
      Restoration of bloodpressure and cardiac performance may not be sufficient to correct these
      alterations. Magnesium is a potent vasodilator which may be used to open up the small
      vessels, in order to reduce organ failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a single-center open label study we evaluated the effects of magnesium sulphate (MgS)
      infusion on the sublingual microcirculation perfusion in fluid resuscitated patients with
      severe sepsis and septic shock within the first 48 hours after ICU admission. Directly prior
      to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic
      variables, sublingual SDF images and standard laboratory tests, were obtained.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>microvascular flow index</measure>
    <time_frame>1 hour</time_frame>
    <description>Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">14</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>severe sepsis and septic shock</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>2 gram in 1 hour</description>
    <arm_group_label>severe sepsis and septic shock</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        severe sepsis and septic shock after adequate fluid resuscitation according to pulmonary
        artery catheter measurements
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severe sepsis and septic shock

        Exclusion Criteria:

          -  pregnancy

          -  oral bleeding

          -  age &lt; 18 years

          -  liver cirrhosis

          -  acute arrhythmias

          -  advanced malignancy or a mean arterial pressure (MAP) &lt; 65 mmHg refractory to
             vasopressors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A Pranskunas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lithuanian university of sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of Lithuanian university of health sciences</name>
      <address>
        <city>Kaunas</city>
        <zip>LT 44307</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2011</study_first_submitted>
  <study_first_submitted_qc>April 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2011</study_first_posted>
  <last_update_submitted>April 4, 2011</last_update_submitted>
  <last_update_submitted_qc>April 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Andrius Pranskunas</name_title>
    <organization>Lithuanian University of Health Sciences</organization>
  </responsible_party>
  <keyword>microcirculation</keyword>
  <keyword>SDF</keyword>
  <keyword>magnesium sulfate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

